News | July 03, 2012

New Echocardiographic Methods Find Cardiac Dysfunction in One of Four Morbidly Obese Patients

July 3, 2012 — Researchers have announced the results of a study that highlights new echocardiographic methods that can detect latent systolic function in obese patients.

“Obesity is a major public health problem in the United States, and increases the risk of various cardiovascular diseases. Our study evaluated both the relaxation and contraction phase of the heart’s function in morbidly obese patients referred for preoperative evaluation prior to bariatric surgery. We found that two out of five morbidly obese patients have abnormalities in the relaxation phase of the heart (stiff hearts). Furthermore, one in five of those with relaxation abnormalities also have early evidence of contraction abnormalities,” explained Farooq A. Chaudhry, MD, Associate Chief of Cardiology, Director of Echocardiography and Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, New York, NY, senior author of the study.

The study, led by primary investigator Harikrishna Makani, also from Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, included 340 patients who were referred for stress echocardiography for pre-operative evaluation prior to bariatric surgery. The authors utilized echocardiographic blood and tissue Doppler imaging parameters specifically assessing the relaxation and contraction phase of the heart. They found that abnormalities in the relaxation phase in this patient population are frequently accompanied by early contraction abnormalities as well.

A poster based on the results will be displayed on Monday, July 2, in the poster and exhibit hall at the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions at the Gaylord National, National Harbor, Md. Researchers will be available in the Hall from 12:15 p.m. to 1:45 p.m.

For more information: www.asecho.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now